1471 drugs samples manufactured in HP failed quality tests in past two years

Shimla:  A total of 1,471 drugs samples manufactured in Himachal Pradesh have failed quality tests over the past two years till February 25, 2025, prompting legal action against six companies, Health and Family Welfare Minister Dhani Ram Shandil informed the Vidhan Sabha on Wednesday.

Responding to a query by Congress MLA Kewal Singh Pathania, the minister provided a district-wise breakdown of the substandard drug samples. According to the data, 33 samples were from firms based in Kangra, 302 in Sirmaur, 1,190 in Solan, and 46 in Una.

Actions such as suspension of product permissions for up to six months, issuance of show-cause notices, cancellation or surrender of licenses, and product seizures have been taken against erring pharma units, he said, adding that investigations were underway in some cases.

As per PTI report, Deputy Chief Minister Mukesh Agnihotri informed the House that 2,561 multipurpose workers were recruited in the state over the past three years till January 15, 2024, in line with departmental policies.

Responding to a question by Congress MLA Bhuvneshwar Gaur, he said that 2,502 workers were recruited in the Jal Shakti department, followed by 26 in Agriculture, 12 in Panchayati Raj, 10 in Rural Development, five in Planning, and two in Ayush.

In a reply to another question by BJP MLA Randhir Sharma, Agnihotri said the state government would procure electric buses through NABARD.

The auction process has been completed, and supply orders are being issued to the successful bidders. It is an important step towards reducing pollution, he added.

Education Minister Rohit Thakur informed the House that an expenditure of Rs 822.71 crore was incurred under the Samagra Shiksha Abhiyan in the state over the past two years.

Responding to a query by BJP MLA Sudhir Sharma, Thakur said the funds were mainly utilised for teachers’ salaries, free uniforms and books, vocational education, construction works, sports grants, and teacher training.

During 2023-24, Rs 421 crore out of the sanctioned Rs 485.97 crore was spent, while the entire sanctioned amount of Rs 336.74 crore was utilised in 2024-25, he added.

Related Posts

  • Pharma
  • July 24, 2025
  • 294 views
Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

  • Pharma
  • July 22, 2025
  • 343 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra